The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ucedane

200 milligram(s) Dispersible tablet

Eurocept International B.V.EU/1/17/1202/001-002

Main Information

Trade NameUcedane
Active SubstancesCarglumic acid
Strength200 milligram(s)
Dosage FormDispersible tablet
Licence HolderEurocept International B.V.
Licence NumberEU/1/17/1202/001-002

Group Information

ATC CodeA16AA Amino acids and derivatives
A16AA05 carglumic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued23/06/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back